“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  CL

COLGATE PALMOLIVE CO

LISTEDNYSE
SYMBOLCL
SIC2844
STATE OF INC.DE
FISCAL YEAR ENDSDecember 31
CIK21665

PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions05101520252016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.001.002.003.004.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt7,83999.3
Stockholders' equity540.7
Total capitalization7,893100.0

797,172,829 shares outstanding at 30 June 2026 (cover page of the 10-Q filed 31 July 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities7,839
Long-term debt, noncurrent6,871
Current maturities1,115

CAPITAL STOCK 12/31/25

Common shares authorized2,000,000,000
Common shares issued1,465,706,360
Treasury shares664,466,836
Par or stated value per share ($)1
Outstanding at 6/30/26797,172,829

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20252.0879.1
20242.4870.7
20231.9169.0
20221.8687.3
20211.7970.2

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware.

BUSINESS: Classified by the SEC under Standard Industrial Classification 2844, Perfumes, Cosmetics & Other Toilet Preparations. Large accelerated filer. Principal executive office: 300 Park Ave, New York, NY 10022. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues20,38220,10119,457
Cost of revenues8,1317,9408,131
Gross profit12,25112,16111,326
Research and development366355343
Selling, general and administrative7,9037,7297,151
Depreciation and amortization630605567
Operating income3,3064,2683,984
Interest expense267292287
Income before income taxes3,0593,9563,392
Income taxes798907937
Net income2,1322,8892,300
Earned per share, diluted ($)2.633.512.77
Dividends per share ($)2.082.481.91

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents1,2881,096
Receivables, net1,6751,521
Inventories2,0321,987
Total current assets5,7095,317
Property, plant and equipment, net4,6604,422
Goodwill3,1223,272
Total assets16,33016,046
Total current liabilities6,8535,759
Long-term debt6,8717,289
Total liabilities15,96515,502
Stockholders' equity54212
Total liabilities and equity16,33016,046

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/2520,3823,3062,13210.52.632.084,1985643,63416,33015,9657,839543948.1145.17
12/31/2420,1014,2682,88914.43.512.484,1075613,54616,04615,5027,0052121362.733.04
12/31/2319,4573,9842,30011.82.771.913,7457053,04016,39315,4368,239609377.713.53
12/31/2217,9672,8931,7859.92.131.862,5566961,86015,73114,9258,755401445.121.83
12/31/2117,4213,3322,16612.42.551.793,3255672,75815,04014,0697,206609355.711.83
12/31/2016,4713,8852,69516.43.141.753,7194093,31015,92014,8197,343743362.79.88
12/31/1915,6933,5542,36715.12.751.713,1333352,79815,03414,4767,5871172023.164.85
12/31/1815,5443,6942,40015.42.751.663,0564362,62012,16111,9646,354(102)-2352.9-62.29
12/31/1715,4543,7072,02413.12.281.593,0545532,50112,67612,4336,566(60)-3373.3-109.43
12/31/1615,1953,9552,44116.12.72–3,1415932,54812,12312,1066,520(243)-1004.5-26.83

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

COLGATE PALMOLIVE CO
CIK 21665 · EIN 13-1815595

PRINCIPAL OFFICE:

300 Park Ave, New York, NY 10022
Tel.: 2123102000

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

2844 · Perfumes, Cosmetics & Other Toilet Preparations

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 23 February 2026

FORMER NAMES:

COLGATE PALMOLIVE CO

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

7/31/2610-Qperiod 6/30/26
7/31/268-Kperiod 7/31/26
5/13/268-Kperiod 5/8/26
5/1/2610-Qperiod 3/31/26
5/1/268-Kperiod 4/30/26
4/9/268-Kperiod 4/8/26
3/25/26DEF 14Aperiod 5/8/26
3/17/268-Kperiod 3/17/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/23/26) · 10-K FY2024 (filed 2/13/25) · 10-K FY2023 (filed 2/15/24) · 10-K FY2022 (filed 2/16/23) · 10-K FY2021 (filed 2/17/22) · 10-K FY2020 (filed 2/18/21) · 10-K FY2019 (filed 2/21/20) · 10-K FY2018 (filed 2/21/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice